{"id":13671,"date":"2023-01-13T18:52:30","date_gmt":"2023-01-13T13:22:30","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=13671"},"modified":"2026-03-30T13:42:43","modified_gmt":"2026-03-30T08:12:43","slug":"sarm1","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/","title":{"rendered":"SARM1 Inhibitors: An Answer For Neurodegenerative Diseases"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Neurological disorders are considered the second leading cause of death and the primary cause of long-term disability, worldwide. In fact, over 6.5 million neurological disorder related deaths are reported annually, globally. Further, according to a report published by the United Nation (UN), close to 1 billion people, across the globe, suffer from various types of neurological disorders, including <a href=\"https:\/\/www.rootsanalysis.com\/reports\/alzheimers-disease-market\/247.html\">Alzheimer\u2019s disease<\/a>, Parkinson\u2019s disease, amyotrophic lateral sclerosis and &nbsp;multiple sclerosis. The growing number of patients suffering from neurodegenerative disorders has imposed a huge burden, in terms of finances as well as resources, on&nbsp; the overall healthcare system. In this context, it is worth mentioning that the annual expenditure associated with neurological disorder care in 2020 was more than USD 655 billion, in the US alone. SARM1 inhibitors have the potential to overcome these challenges and address the unmet need.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"613\" height=\"95\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Rising-Burden-Neuro-Disorders-Roots-Analysis.webp\" alt=\"SARM1 inhibitors have the potential to overcome these challenges and address the unmet need.\" class=\"wp-image-19808\" style=\"object-fit:contain;width:690px;height:107px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Rising-Burden-Neuro-Disorders-Roots-Analysis.webp 613w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Rising-Burden-Neuro-Disorders-Roots-Analysis-300x46.webp 300w\" sizes=\"auto, (max-width: 613px) 100vw, 613px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Given the fact that majority of the current treatment options have proven to be inadequate, especially for axonal degeneration associated neurological disorders, there is a high demand for highly effective therapeutics targeting neurological disorders. <em>Sterile Alpha and toll \/ Interleukin-1 Receptor Motif-Containing 1<\/em> (SARM1), an NADase enzyme, has been found to play a critical role in inducing axonal degeneration, which is a central pathological feature in various neurodegenerative disorders. Currently, several studies are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorder. The role of SARM1 in neurodegenerative disorders is outlined below.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"537\" height=\"400\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Representation-for-Axon-Denegration-Roots-Analysis.webp\" alt=\"Role of Sterile Alpha and TIR Motif Containing-1 in Neurodegenerative Disorders\" class=\"wp-image-19792\" style=\"object-fit:contain;width:493px;height:366px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Representation-for-Axon-Denegration-Roots-Analysis.webp 537w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Representation-for-Axon-Denegration-Roots-Analysis-300x223.webp 300w\" sizes=\"auto, (max-width: 537px) 100vw, 537px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Axonal degeneration is a principal pathophysiological event for the occurrence of neurological disorders. SARM1, an NADase enzyme, depletes the energy stored in axons upon activation and initiates axonal degeneration process. The process leads to generation of metastable pool of damaged axons that remain structurally and functionally viable but are subjected to degeneration in the absence of external intervention. However, it has been reported that small molecules, such as isoquinoline inhibitors (DSRM-3716), can deactivate the phenotype of SARM1 enzyme and prevent axon degeneration. Therefore, inhibition of SARM1 by small molecules can be used to treat axonopathies of the central and peripheral nervous system and allow recovery of metastable pool of damaged axons.The mechanism of action of SARM1 inhibitors is outlined below.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"613\" height=\"130\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Activation-Representation-Roots-Analysis.webp\" alt=\"The mechanism of action of SARM1 inhibitors\" class=\"wp-image-19801\" style=\"object-fit:contain;width:651px;height:138px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Activation-Representation-Roots-Analysis.webp 613w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Activation-Representation-Roots-Analysis-300x64.webp 300w\" sizes=\"auto, (max-width: 613px) 100vw, 613px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\">Key Milestones Related to SARM1 Inhibitors<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, there are no available treatment options that target axonal degeneration. However, SARM1 has become a potential therapeutic target and several studies are evaluating various SARM1 inhibitors as therapeutic agents for the treatment of multiple neurological disorders. Therefore, the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/sarm1-inhibitors-market.html\">SARM1 inhibitor market<\/a> is an evolving area of research within the neurodegeneration and associated diseases domain.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"613\" height=\"96\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Key-Milestones-Roots-Analysis.webp\" alt=\"Key Milestones Related to SARM1 Inhibitors\" class=\"wp-image-19793\" style=\"object-fit:contain;width:753px;height:118px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Key-Milestones-Roots-Analysis.webp 613w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Key-Milestones-Roots-Analysis-300x47.webp 300w\" sizes=\"auto, (max-width: 613px) 100vw, 613px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\">What is the Current Industry Landscape and Upcoming Trends in the SARM1 Inhibitor Market?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">As per a recent market report by Roots Analysis, around 15 small molecule and biologics are being evaluated in pre-clinical and discovery stages for their potential to be an <a href=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1-inhibitors-market\/\">SARM1 inhibitor<\/a> candidate.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"613\" height=\"96\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Industry-landscape-Roots-Analysis.webp\" alt=\"Current Industry Landscape and Upcoming Trends in the SARM1 Inhibitor Market\" class=\"wp-image-19799\" style=\"object-fit:contain;width:754px;height:118px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Industry-landscape-Roots-Analysis.webp 613w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/SARM1-Industry-landscape-Roots-Analysis-300x47.webp 300w\" sizes=\"auto, (max-width: 613px) 100vw, 613px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/sarm1-inhibitors-market\/request-sample.html\">SAMPLE REPORT<\/a>&nbsp;on SARM1 inhibitors by Roots Analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[1] Source: https:\/\/www.fightchronicdisease.org\/latest-news\/neurodegenerative-disease-costs-exceed-655-billion-year-medical-expenses-and-economic<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neurological disorders are considered the second leading cause of death and the primary cause of long-term disability, worldwide. In fact, over 6.5 million neurological disorder related deaths are reported annually, globally. Further, according to a report published by the United Nation (UN), close to 1 billion people, across the globe, suffer from various types of [&hellip;]<\/p>\n","protected":false},"author":67,"featured_media":16723,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[369],"tags":[894,901,892,891,890],"class_list":["post-13671","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neurodegeneration","tag-neurodegenerative-disorders","tag-progressive-neurodegenerative-disease","tag-sarm1","tag-sarm1-inhibitors","tag-sarm1-pathway"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SARM1 Inhibitors: Answer For Neurodegenerative Diseases<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, around 15 biologics are being evaluated in pre-clinical and discovery stages as candidates for SARM1 inhibitors\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SARM1: A Therapeutic Target For Neurodegenerative Diseases\" \/>\n<meta property=\"og:description\" content=\"Currently, several studies are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-13T13:22:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T08:12:43+00:00\" \/>\n<meta name=\"author\" content=\"Rohit Pareek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"SARM1: A Therapeutic Target For Neurodegenerative Diseases\" \/>\n<meta name=\"twitter:description\" content=\"Currently, several studies are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders.\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rohit Pareek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/\"},\"author\":{\"name\":\"Rohit Pareek\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/6c30c36f3d821b530eb72afe813da331\"},\"headline\":\"SARM1 Inhibitors: An Answer For Neurodegenerative Diseases\",\"datePublished\":\"2023-01-13T13:22:30+00:00\",\"dateModified\":\"2026-03-30T08:12:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp\",\"keywords\":[\"neurodegenerative disorders\",\"progressive neurodegenerative disease\",\"sarm1\",\"sarm1 inhibitors\",\"sarm1 pathway\"],\"articleSection\":[\"Neurodegeneration\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/\",\"name\":\"SARM1 Inhibitors: Answer For Neurodegenerative Diseases\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp\",\"datePublished\":\"2023-01-13T13:22:30+00:00\",\"dateModified\":\"2026-03-30T08:12:43+00:00\",\"description\":\"According to Roots Analysis, around 15 biologics are being evaluated in pre-clinical and discovery stages as candidates for SARM1 inhibitors\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article SARM1 targeting therapies at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/sarm1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SARM1 Inhibitors: An Answer For Neurodegenerative Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/6c30c36f3d821b530eb72afe813da331\",\"name\":\"Rohit Pareek\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g\",\"caption\":\"Rohit Pareek\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SARM1 Inhibitors: Answer For Neurodegenerative Diseases","description":"According to Roots Analysis, around 15 biologics are being evaluated in pre-clinical and discovery stages as candidates for SARM1 inhibitors","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/","og_locale":"en_US","og_type":"article","og_title":"SARM1: A Therapeutic Target For Neurodegenerative Diseases","og_description":"Currently, several studies are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders.","og_url":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2023-01-13T13:22:30+00:00","article_modified_time":"2026-03-30T08:12:43+00:00","author":"Rohit Pareek","twitter_card":"summary_large_image","twitter_title":"SARM1: A Therapeutic Target For Neurodegenerative Diseases","twitter_description":"Currently, several studies are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders.","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Rohit Pareek","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/"},"author":{"name":"Rohit Pareek","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/6c30c36f3d821b530eb72afe813da331"},"headline":"SARM1 Inhibitors: An Answer For Neurodegenerative Diseases","datePublished":"2023-01-13T13:22:30+00:00","dateModified":"2026-03-30T08:12:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/"},"wordCount":488,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/01\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp","keywords":["neurodegenerative disorders","progressive neurodegenerative disease","sarm1","sarm1 inhibitors","sarm1 pathway"],"articleSection":["Neurodegeneration"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/","url":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/","name":"SARM1 Inhibitors: Answer For Neurodegenerative Diseases","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/01\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp","datePublished":"2023-01-13T13:22:30+00:00","dateModified":"2026-03-30T08:12:43+00:00","description":"According to Roots Analysis, around 15 biologics are being evaluated in pre-clinical and discovery stages as candidates for SARM1 inhibitors","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/sarm1\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/01\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/01\/RootsAnalysis_FeaturedImage_Neuro_Disease.webp","width":150,"height":150,"caption":"This is a feature image for blog article SARM1 targeting therapies at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/sarm1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"SARM1 Inhibitors: An Answer For Neurodegenerative Diseases"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/6c30c36f3d821b530eb72afe813da331","name":"Rohit Pareek","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fa811baf30c51b9cdf65502f5144cb65ac836f3cc62009242648e108f71364e1?s=96&d=mm&r=g","caption":"Rohit Pareek"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=13671"}],"version-history":[{"count":60,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13671\/revisions"}],"predecessor-version":[{"id":22155,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/13671\/revisions\/22155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16723"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=13671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=13671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=13671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}